TrialBMC cancer2022

A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.

Subhadip Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.